Kodak to partner in PACS with Perot SystemsFilm and PACS company Eastman Kodak has signed a letter of intent with Perot Systems to work together on installing institution-wide PACS networks. Dallas-based Perot Systems will provide networking and
Film and PACS company Eastman Kodak has signed a letter of intent with Perot Systems to work together on installing institution-wide PACS networks. Dallas-based Perot Systems will provide networking and integration services in large-scale PACS situations. The deal allows Kodak to offer customers both PACS and systems integration services, according to the Rochester, NY-based firm.
In other Kodak news, the firm is partnering with archiving firm Storage Technology of Louisville, CO, to bring support for digital linear tape to Kodak's long-term archiving offerings. The DLT addition will complement Kodak's other DICOM-compliant, long-term storage products, which include CD libraries.
The DLT subsystem employs the StorageTek automated cartridge system to meet department, hospital, or enterprise-wide long-term archiving needs, according to Kodak. Like the other two archiving levels in the Kodak Digital Science medical image and information library, the long-term archiving offering features JPEG data compression, autorouting, prefetching, and support for information transfer via Ethernet, 100 BaseT, ATM, T1, and ISDN lines.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.